Pre-eclampsia test (PE)

Product introduction

cell-free RNA (cfRNA) in blood and DNA methylation are combined with AI intelligence to predict the possibility of preeclampsia in early pregnancy, to guide the clinical treatment for prevention.

Product advantages

Precision——combined with artificial intelligence for more accurate prediction

Advance——brought forward to 16th week or even earlier

Applicable population

all women in early pregnancy

Service process

prenatal counseling

identify the clinical indications

sample collection

4ml of whole blood,

and plasma was isolated by centrifugation


sample transport

cold chain transport at -80°C

full range temperature monitoring

pre-eclampsia testing

15 workdays

detection report

predicts possibility of pre-eclamsia